This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
CD47 monoclonal antibody, clone BRIC126
catalog :
MAB5279
quantity :
200 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human, dogs, bovine
application :
immunoprecipitation, flow cytometry, immunohistochemistry - frozen section
product information
catalog id :
MAB5279
product name :
CD47 monoclonal antibody, clone BRIC126
product description :
Mouse monoclonal antibody raised against native purified CD47.
clone name :
BRIC126
isotype :
IgG2b
gene name :
CD47
gene alias :
IAP MER6 OA3
gene description :
CD47 molecule
immunogen :
Native purified CD47 from human erythrocytes.
form :
Liquid
recommend dilutions :
Flow Cytometry (10 ul of the suggested working dilution to label 10 6 cells in 100 ul). The optimal working dilution should be determined by the end user.
storage buffer :
In Tris-glycerine, pH 7.8 (0.09% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
specificity :
This antibody recognizes the human CD47 cell surface glycoprotein, a heavily N-glycosylated 47-52kD molecule. CD47 is expressed on all cells and tissues so far examined, although expression is reduced on erythrocytes of the rare Rh null phenotype.
species reactivity cross reactivity :
Bovine,Dog,Human,Pig
application key :
IP,IHC-Fr,Flow Cyt
size :
200 ug
autodate :
2010-01-04
updatetime :
2011-10-19 17:24:28
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments